Its not clear how much of these copayment support revenues is shared with Express Scripts
For tennis elbow, golfers elbow, and other elbow tendon injuries, typical research protocols use 0.25 to 0.5 mg daily via subcutaneous injection near the injury site for 4 to 8 weeks
Published: May 7, 2024 Written by Saya Des Marais Medically Reviewed by Goldina Erowele, PharmD, MBA Published: May 7, 2024 Key takeaway: Wellbutrin (bupropion) is generally not recommended as a primary treatment for OCD, and may worsen symptoms in some individuals

In This Episode [00:00] Earth Day reunion with Cheyenne and Omar from PureWay [02:25] Easy ways to get a free sharps container [03:44] How PureWays proprietary recycling process actually works [04:46] Why safe sharps disposal matters for sanitation workers and the planet [06:42] Whats new at PureWay over the past year [08:49] How they simplified waste management for at-home consumers [10:42] PureWays AI integration into operations [14:04] Why corporate sustainability gatekeeping misses the bigger picture [18:22] What actually happens when sharps go in the household trash [21:22] Practical steps for safe sharps disposal at home [23:53] What NAD+ actually is and why I take NR instead [26:34] Why doctors dont always know about preventative supplements [33:39] How patient communities reshape what companies offer [36:55] The exclusive PureWay PPSWG partnership with 365+ pharma companies [44:20] The microwave technology that recycles the plastic [50:12] How to enter the Earth Month giveaway [53:10] The water and energy cost of AI and modern waste systems [54:43] Closing thoughts on small habits that scale Resources & Links PureWay Compliance: Consumer site (the one you want for at-home use): purewayathome.com Main corporate site: pureway.com Instagram: @purewaycompliance LinkedIn: PureWay Compliance Earth Month discount code: Use EARTH20 at purewayathome.com for 20% off, good through 5/13/2026

Benefits of Epithalon Therapy Telomere Extension & Longevity Support Epithalon has been shown in studies to activate telomerase, the enzyme that lengthens telomeres (the protective ends of chromosomes)
A potential solution would be the bolstering of an alternative commercialization path outside of pharma